Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease. (Q50553843)

15 March 2018

title

Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease. (English)

1 reference

15 March 2018

1 reference

Lirong Jin

1

1 reference

15 March 2018

Jian Wang

2

1 reference

15 March 2018

Lei Zhao

3

1 reference

15 March 2018

Hang Jin

4

1 reference

15 March 2018

Guoqiang Fei

5

1 reference

15 March 2018

Yuwen Zhang

6

1 reference

15 March 2018

Mengsu Zeng

7

1 reference

15 March 2018

Chunjiu Zhong

8

1 reference

15 March 2018

language of work or name

English

0 references

publication date

24 November 2010

1 reference

15 March 2018

published in

Brain

1 reference

15 March 2018

volume

134

1 reference

15 March 2018

issue

Pt 1

1 reference

15 March 2018

page(s)

50-58

1 reference

15 March 2018

Iron metabolism in Parkinsonian syndromes

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Increased nigral iron content in postmortem parkinsonian brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Diagnostic criteria for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Imaging iron stores in the brain using magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Susceptibility weighted imaging (SWI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

The effect of age on the non-haemin iron in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Aceruloplasminemia: molecular characterization of this disorder of iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Biochemical aspects of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Iron metabolism in copper-deficient swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Genetics of iron regulation and the possible role of iron in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Potential role of high-field MRI for studies in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

Iron, brain ageing and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ319

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWQ319

1 reference

15 March 2018

PubMed ID

21109502

1 reference

15 March 2018